HR. 8339In Committee
Drug Origin Transparency Act of 2026
Require drug origin transparency by identifying where covered drugs are manufactured and sourced
Plain-English overview
What this bill does
Require drug origin transparency by identifying where covered drugs are manufactured and sourced
Key points
- Require drug origin disclosure
Current status
Where it stands
Status
In Committee
Latest action
2026-04-16 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedHealth